Navigation Links
Early Drug Treatment May Cut Multiple Sclerosis Risk
Date:10/6/2009

Improved rates of prevention or delay of full-blown disease seen in treated study patients

TUESDAY, Oct. 6 (HealthDay News) -- Among patients who show early signs of multiple sclerosis, treatment with a drug called glatiramer acetate appears to halve the risk that they will develop full-blown disease, new research suggests.

About 85 percent of patients who are diagnosed with multiple sclerosis first show signs of a "clinical event" that goes away. But many people who have this happen -- about one-third -- don't go on to develop the disease, and most of the rest won't be severely disabled, research has shown.

In the new study, published in Oct. 6 online edition of The Lancet, 481 people who showed possible signs of multiple sclerosis were assigned to receive either a placebo or glatiramer acetate for up to 36 months. The dosage for those who received the active drug was 20 milligrams per day.

The researchers found that glatiramer acetate reduced the risk of developing the disease by 45 percent compared to the placebo, and it took longer for some patients to develop the disease -- it was an average of about two years for those who took the drug compared to about one year for those who didn't.

Injection-related side effects were common: more than half of those who were given glatiramer acetate developed problems around the site of their injections, and about 19 percent had reactions right after receiving the treatment. By comparison, 24 percent of those who were given the placebo had reactions at the site of their injections, and only 5 percent had problems immediately after the treatment, according to the study authors.

"This study establishes glatiramer acetate as an option for patients with clinically isolated syndrome who choose to start treatment early to improve control of the underlying disease process," the researchers concluded.

More information

Learn more about multiple sclerosis from the National Multiple Sclerosis Society.



-- Randy Dotinga



SOURCE: The Lancet, news release, Oct. 6, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Early H1N1 Vaccination Saves Lives, Cuts Costs: Study
2. New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered
3. Molecular imaging holds promise for early intervention in common uterine cancer
4. A potential new imaging agent for early diagnosis of most serious skin cancer
5. Clearly Contacts Director of Web Sales Named as One of Canada's Top Online Marketers of 2009
6. Training clinicians helps reduce rates of early childhood cavities
7. Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women
8. Analysis Shows Narrow Age Rating Would Raise Premiums by Nearly 50 Percent, Causing Many Young and Healthy to Forgo Coverage
9. Switching early breast cancer patients to exemestane improves long-term survival
10. LA County Announces: Nearly 40,000 Seniors and Disabled to Lose Home Care Service Hours Due to State Budget Cuts
11. New device finds early signs of eye disease in preemies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: